Impulsive compulsive behaviours (ICBs) in Parkinson’s disease (PD) are a common and devastating side effect of dopamine replacement therapy. In this review we describe the phenomenology, prevalence and risk factors of these patients. Results of behavioural studies assessing the neuropsychological profile emphasize that the ICBs, which are behavioural addictions, are not hedonically motivated. Rather, other factors such as the inability to cope with uncertainty may be triggering ICBs. New insights from functional imaging studies, strengthening the incentive salience hypothesis are discussed and therapeutic guidelines for the management of ICBs in PD are given.